Skip to main content

Prion Diseases clinical trials at UCSF
1 in progress, 1 open to new patients

  • Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

    open to eligible people ages 1–99

    The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young mutation carriers. Antibodies against the flexible tail of Prions have been shown to be protective in mice. The investigators intend to screen mutation carriers and controls for the presence of Prion autoantibodies.

    San Francisco, California and other locations